Key points from article :
Peter Diamandis, a renowned entrepreneur and visionary, has shifted his focus from space travel to anti-ageing technologies, seeing longevity as a vital area for future advancement. Initially captivated by the potential of extending human life to achieve his dream of space exploration, Diamandis has become a leading advocate for anti-ageing research. He believes that exponential technologies, such as AI and biotech, will soon provide the tools to slow, stop, or even reverse ageing.
Diamandis has co-founded numerous companies in the longevity space, including Human Longevity, Fountain Life, and Celularity, and has established venture funds like BOLD Capital, which heavily invests in biotech. He is also behind the $101 million XPRIZE Healthspan, which aims to incentivize breakthroughs in extending the healthy years of life. His efforts include creating exclusive educational trips and summits to foster interest and investment in longevity science.
Diamandis emphasizes that while current advancements might seem accessible only to the wealthy, as with many technological innovations, they will eventually become affordable for the broader public. His philosophy centres on leveraging cutting-edge technology and entrepreneurial spirit to tackle ageing, which he sees as a disease that affects all eight billion people on the planet. He remains optimistic that with continued investment and technological innovation, we could reach "longevity escape velocity"—the point at which life-extending technologies advance faster than ageing itself—within our lifetimes.
